Cite
He P, Niu S, Wang S, et al. Discovery of WS-157 as a highly potent, selective and orally active EGFR inhibitor. Acta Pharm Sin B. 2019;9(6):1193-1203doi: 10.1016/j.apsb.2019.06.010.
He, P., Niu, S., Wang, S., Shi, X., Feng, S., Du, L., Zhang, X., Ma, Z., Yu, B., & Liu, H. (2019). Discovery of WS-157 as a highly potent, selective and orally active EGFR inhibitor. Acta pharmaceutica Sinica. B, 9(6), 1193-1203. https://doi.org/10.1016/j.apsb.2019.06.010
He, Pengxing, et al. "Discovery of WS-157 as a highly potent, selective and orally active EGFR inhibitor." Acta pharmaceutica Sinica. B vol. 9,6 (2019): 1193-1203. doi: https://doi.org/10.1016/j.apsb.2019.06.010
He P, Niu S, Wang S, Shi X, Feng S, Du L, Zhang X, Ma Z, Yu B, Liu H. Discovery of WS-157 as a highly potent, selective and orally active EGFR inhibitor. Acta Pharm Sin B. 2019 Nov;9(6):1193-1203. doi: 10.1016/j.apsb.2019.06.010. Epub 2019 Jun 28. PMID: 31867165; PMCID: PMC6900553.
Copy
Download .nbib